Subscribe to My Feed




Tell a Friend




  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • Important LAC Developments on Clinical Trials

    Monday, March 23rd, 2009

    Argentina and Brazil are creating national registries for clinical trials. Clinical trials are research studies that prospectively assign human participants or groups of humans to one or more health-related interventions (pharmaceuticals, vaccines, surgical procedures, radiological procedures, medical devices, etc.) to evaluate the effects on health outcomes, often undertaken with a view to seeking regulatory approval. […]

    Share

    MERCOSUR Adopts Guidelines on Promotion, Advertising & Marketing of Pharmaceuticals

    Tuesday, December 30th, 2008

    I’ve said here many times that Latin American and Caribbean (LAC) nations tend to take seriously the recommendations, guidelines and other soft norms of the World Health Organization (WHO) on any issue involving public health and/or the environment, and I’ve tried to provide a few examples where WHO work has translated into national laws and […]

    Share

    Brazil to Invest R$25 Million by 2012 on Anti-HIV Vaccines / Brasil vai investir R$25 milhões até 2012 em vacinas anti-HIV

    Sunday, October 5th, 2008

    From Brazil’s National Program on Sexually Transmitted Diseases and AIDS (STD-AIDS):
    R$ 25 million to be invested in Anti-HIV Vaccines by 2012
    During the next four years the Brazilian Ministry of Health will invest R$ 25 million in research into the development of a vaccine against AIDS. The resources will be applied in human resource training, laboratory […]

    Share

    Brazil Finds 3 Promising Candidates for ARVs to Combat AIDS

    Friday, August 29th, 2008

    Synopsis in English: The private Ataulpho de Paiva Foundation (FAP), the Fluminense Federal University (UFF) and the Oswaldo Cruz Institute (IOC, part of the Fiocruz family of public institutions) — all based in Rio de Janeiro state — jointly announced today the discovery of three substances that are good candidates for anti-retroviral medicines to combat […]

    Share

    A Dengue Vaccine by December?

    Tuesday, August 26th, 2008

    During the 60th Annual Meeting of the Brazilian Society for the Advancement of Science (Sociedade Brasileira para o Progresso da Ciência– SBPC) last month held in Campinas, São Paulo, it was announced that Brazil probably will go to market first with a vaccine against dengue and that they may start producing it as early as […]

    Share

    The Need to Improve the Safety of Children’s Medicines

    Friday, September 28th, 2007

    Pharmacovigilance and medicine safety issues in children are relevant to everyone who has an interest in and cares about the health of children.
    In order to gain full marketing authorization, the law in most countries requires pharmaceutical firms to demonstrate that they have tested their medicines in healthy volunteers and patients for possible adverse effects.  These […]

    Share